Cordlife Financial Statements From 2010 to 2025
| CLIFF Stock | USD 0.10 0.00 0.00% |
Check Cordlife Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cordlife Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cordlife financial statements analysis is a perfect complement when working with Cordlife Group Valuation or Volatility modules.
Cordlife |
Cordlife Group Limited Company Operating Margin Analysis
Cordlife Group's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cordlife Group Operating Margin | 0.07 % |
Most of Cordlife Group's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cordlife Group Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Cordlife Group Limited has an Operating Margin of 0.0687%. This is 100.2% lower than that of the Healthcare sector and 100.11% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is 101.25% lower than that of the firm.
Cordlife Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cordlife Group's current stock value. Our valuation model uses many indicators to compare Cordlife Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cordlife Group competition to find correlations between indicators driving Cordlife Group's intrinsic value. More Info.Cordlife Group Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.25 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cordlife Group Limited is roughly 3.94 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cordlife Group's earnings, one of the primary drivers of an investment's value.About Cordlife Group Financial Statements
Cordlife Group stakeholders use historical fundamental indicators, such as Cordlife Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cordlife Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cordlife Group's assets and liabilities are reflected in the revenues and expenses on Cordlife Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cordlife Group Limited. Please read more on our technical analysis and fundamental analysis pages.
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. Cordlife Group Limited was incorporated in 2001 and is headquartered in Singapore. Cordlife operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Cordlife Pink Sheet
Cordlife Group financial ratios help investors to determine whether Cordlife Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cordlife with respect to the benefits of owning Cordlife Group security.